WST West Pharmaceutical Services Inc

Price (delayed)

$329.11

Market cap

$23.97B

P/E Ratio

42.91

Dividend/share

$0.79

EPS

$7.67

Enterprise value

$23.68B

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, ...

Highlights
The stock's price to earnings (P/E) is 15% less than its last 4 quarters average of 50.2 and 10% less than its 5-year quarterly average of 47.8
WST's debt is down by 2.5% year-on-year
WST's EPS is down by 3.9% since the previous quarter but it is up by 3.5% year-on-year
The net income has contracted by 4.2% from the previous quarter but it has grown by 3% YoY
West Pharmaceutical Services's quick ratio has decreased by 34% YoY and by 14% from the previous quarter
WST's equity is down by 7% since the previous quarter and by 3.4% year-on-year

Key stats

What are the main financial stats of WST
Market
Shares outstanding
72.84M
Market cap
$23.97B
Enterprise value
$23.68B
Valuations
Price to book (P/B)
9
Price to sales (P/S)
8.26
EV/EBIT
34.21
EV/EBITDA
28.41
EV/Sales
8.09
Earnings
Revenue
$2.93B
EBIT
$692.2M
EBITDA
$833.5M
Free cash flow
$386.1M
Per share
EPS
$7.67
Free cash flow per share
$5.25
Book value per share
$36.57
Revenue per share
$39.84
TBVPS
$47.36
Balance sheet
Total assets
$3.6B
Total liabilities
$921.7M
Debt
$306.6M
Equity
$2.68B
Working capital
$1.04B
Liquidity
Debt to equity
0.11
Current ratio
2.61
Quick ratio
1.74
Net debt/EBITDA
-0.35
Margins
EBITDA margin
28.5%
Gross margin
37.2%
Net margin
19.4%
Operating margin
22%
Efficiency
Return on assets
15.3%
Return on equity
20.4%
Return on invested capital
27.5%
Return on capital employed
23.4%
Return on sales
23.6%
Dividend
Dividend yield
0.24%
DPS
$0.79
Payout ratio
10.3%

WST stock price

How has the West Pharmaceutical Services stock price performed over time
Intraday
2.81%
1 week
3.29%
1 month
-1.24%
1 year
-14.55%
YTD
-6.53%
QTD
-0.09%

Financial performance

How have West Pharmaceutical Services's revenue and profit performed over time
Revenue
$2.93B
Gross profit
$1.09B
Operating income
$643.5M
Net income
$568.7M
Gross margin
37.2%
Net margin
19.4%
The operating margin has declined by 9% year-on-year and by 3.9% since the previous quarter
WST's operating income is down by 8% YoY and by 4.8% from the previous quarter
West Pharmaceutical Services's gross margin has decreased by 4.4% YoY and by 2.9% from the previous quarter
The gross profit has contracted by 3.6% from the previous quarter and by 3.1% YoY

Growth

What is West Pharmaceutical Services's growth rate over time

Valuation

What is West Pharmaceutical Services stock price valuation
P/E
42.91
P/B
9
P/S
8.26
EV/EBIT
34.21
EV/EBITDA
28.41
EV/Sales
8.09
The stock's price to earnings (P/E) is 15% less than its last 4 quarters average of 50.2 and 10% less than its 5-year quarterly average of 47.8
WST's EPS is down by 3.9% since the previous quarter but it is up by 3.5% year-on-year
The price to book (P/B) is 12% lower than the 5-year quarterly average of 10.2 and 10% lower than the last 4 quarters average of 10.0
WST's equity is down by 7% since the previous quarter and by 3.4% year-on-year
The P/S is 14% below the last 4 quarters average of 9.6 and 6% below the 5-year quarterly average of 8.8

Efficiency

How efficient is West Pharmaceutical Services business performance
WST's return on invested capital is down by 4.8% since the previous quarter and by 3.8% year-on-year
West Pharmaceutical Services's ROE has decreased by 4.2% YoY and by 3.3% from the previous quarter
WST's return on sales is down by 4.1% since the previous quarter
The company's return on assets fell by 3.2% QoQ and by 3.2% YoY

Dividends

What is WST's dividend history
DPS
$0.79
Dividend yield
0.24%
Payout ratio
10.3%
Recent dividends

Financial health

How did West Pharmaceutical Services financials performed over time
West Pharmaceutical Services's quick ratio has decreased by 34% YoY and by 14% from the previous quarter
West Pharmaceutical Services's current ratio has decreased by 28% YoY and by 9% QoQ
WST's debt is 89% smaller than its equity
WST's equity is down by 7% since the previous quarter and by 3.4% year-on-year
WST's debt is down by 2.5% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.